AH: Heidelberg Pharma Participates in Franco-German Joint Venture Emergence Therapeutics and Signs Collaboration and License Agreement
AH: Partner Magenta Therapeutics Exercises Option to Further Develop Antibody Targeted Amanitin Conjugates Targeted to CD45
PR: Heidelberg Pharma Announces Participation at Various Conferences
PR: Notice to Holders of the convertible bonds issued by Heidelberg Pharma AG
PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019
PR: Heidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project
PR: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
PR: Heidelberg Pharma Receives Milestone Payment from Partner Telix
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2019
PR: Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019
PR: Heidelberg Pharma announces financial figures for fiscal year 2018 and provides business update
PR: Heidelberg Pharma Receives Milestone Payment From Partner Link Health
